146 related articles for article (PubMed ID: 12526179)
1. Production of trans-lentiviral vector with predictable safety.
Kappes JC; Wu X; Wakefield JK
Methods Mol Med; 2003; 76():449-65. PubMed ID: 12526179
[No Abstract] [Full Text] [Related]
2. A multigene lentiviral vector system based on differential splicing.
Zhu Y; Planelles V
Methods Mol Med; 2003; 76():433-48. PubMed ID: 12526178
[No Abstract] [Full Text] [Related]
3. Development of a novel trans-lentiviral vector that affords predictable safety.
Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC
Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827
[TBL] [Abstract][Full Text] [Related]
4. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
[TBL] [Abstract][Full Text] [Related]
5. A new-generation stable inducible packaging cell line for lentiviral vectors.
Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L
Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062
[TBL] [Abstract][Full Text] [Related]
6. Development of foamy virus vectors.
Vassilopoulos G; Josephson NC; Trobridge G
Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
[No Abstract] [Full Text] [Related]
7. A highly efficient gene delivery system derived from feline immunodeficiency virus (FIV).
Sauter SL; Gasmi M; Dubensky TW
Methods Mol Med; 2003; 76():405-32. PubMed ID: 12526177
[No Abstract] [Full Text] [Related]
8. Design of a trans protease lentiviral packaging system that produces high titer virus.
Westerman KA; Ao Z; Cohen EA; Leboulch P
Retrovirology; 2007 Dec; 4():96. PubMed ID: 18163907
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral vectors--the promise of gene therapy within reach?
Amado RG; Chen IS
Science; 1999 Jul; 285(5428):674-6. PubMed ID: 10454923
[No Abstract] [Full Text] [Related]
10. Safety considerations in vector development.
Kappes JC; Wu X
Somat Cell Mol Genet; 2001 Nov; 26(1-6):147-58. PubMed ID: 12465466
[TBL] [Abstract][Full Text] [Related]
11. RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.
Stornaiuolo A; Piovani BM; Bossi S; Zucchelli E; Corna S; Salvatori F; Mavilio F; Bordignon C; Rizzardi GP; Bovolenta C
Hum Gene Ther Methods; 2013 Aug; 24(4):228-40. PubMed ID: 23767932
[TBL] [Abstract][Full Text] [Related]
12. Controlling elements in replication of the human immunodeficiency virus type 1.
Li X; Quan Y; Wainberg MA
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):443-54. PubMed ID: 9193800
[TBL] [Abstract][Full Text] [Related]
13. Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titer.
Dubensky TW; Sauter SL
Methods Mol Med; 2003; 76():309-30. PubMed ID: 12526171
[No Abstract] [Full Text] [Related]
14. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
15. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.
Kent SJ; Stallard V; Corey L; Hu SL; Morton WR; Gritz L; Panicali DL; Greenberg PD
AIDS Res Hum Retroviruses; 1994 May; 10(5):551-60. PubMed ID: 7917517
[TBL] [Abstract][Full Text] [Related]
17. Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.
Carrondo MJ; Merten OW; Haury M; Alves PM; Coroadinha AS
Hum Gene Ther; 2008 Feb; 19(2):199-210. PubMed ID: 18092921
[TBL] [Abstract][Full Text] [Related]
18. Gene delivery by lentivirus vectors.
Cockrell AS; Kafri T
Mol Biotechnol; 2007 Jul; 36(3):184-204. PubMed ID: 17873406
[TBL] [Abstract][Full Text] [Related]
19. Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems.
Matukonis M; Li M; Molina RP; Paszkiet B; Kaleko M; Luo T
Hum Gene Ther; 2002 Jul; 13(11):1293-303. PubMed ID: 12162812
[TBL] [Abstract][Full Text] [Related]
20. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication.
Rizvi TA; Ali J; Phillip PS; Ghazawi A; Jayanth P; Mustafa F
Virology; 2009 Mar; 385(2):464-72. PubMed ID: 19157480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]